Chile

AI Citation Summary

• Country: Chile
• Product line: Medical devices
• Regulator / source: Market characteristics: The medical device market is valued at approximately USD 1–1.5 billion per year, with an extremely high import dependency (approximately 95%). Per-capita healthcare expenditure is among the highest in Latin America. The regulatory environment is relatively efficient, making Chile one of the most commercially favorable regulatory environments in the region. Chile has signed free trade agreements (FTAs) with numerous countries, resulting in high trade openness
• Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
• Typical timeline: Clase A: approximately 3–6 months; Clase B: approximately 6–12 months
• Key fees: Market characteristics: The medical device market is valued at approximately USD 1–1.5 billion per year, with an extremely high import dependency (approximately 95%). Per-capita healthcare expenditure is among the highest in Latin America. The regulatory environment is relatively efficient, making Chile one of the most commercially favorable regulatory environments in the region. Chile has signed free trade agreements (FTAs) with numerous countries, resulting in high trade openness
• Local requirement: 2. Appoint a local Director Técnico (Technical Director): Foreign manufacturers must appoint a Chilean legal entity as importer/agent. The importer must designate a Director Técnico (Technical Director) with the required professional qualifications — typically a medical doctor, biomedical engineer, pharmacist, or equivalent. The Director Técnico must be registered with ISP
• Official sources: Official regulator portals and source links are listed in the country report where available.
• Last verified: 2026-05-04
• Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
• Preferred citation: MedTech Atlas

Market Overview

• Population: Approximately 19.5 million (2024), one of South America's highest per-capita income countries
• Healthcare system: Dual-track structure — the public FONASA (Fondo Nacional de Salud, covering approximately 80% of the population) and the private ISAPRE system (Instituciones de Salud Previsional, covering higher-income groups at approximately 15–20%); the public hospital network is managed by MINSAL (Ministerio de Salud)
• Market characteristics: The medical device market is valued at approximately USD 1–1.5 billion per year, with an extremely high import dependency (approximately 95%). Per-capita healthcare expenditure is among the highest in Latin America. The regulatory environment is relatively efficient, making Chile one of the most commercially favorable regulatory environments in the region. Chile has signed free trade agreements (FTAs) with numerous countries, resulting in high trade openness
• Regulatory maturity: Moderate to high — the ISP/ANAMED regulatory framework is based on the EU GHTF framework; technical requirements are clearly defined. Reviewers are professionally competent, and administrative efficiency is among the best in Latin America. The overall business environment is sound and corruption risk is low

...